Company Filing History:
Years Active: 2010
Title: Bruce Innis: Innovator in Vaccine Development
Introduction
Bruce Innis is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of vaccine development, particularly in relation to human papillomaviruses (HPV). His work has implications for treating infections caused by these viruses, showcasing his commitment to advancing public health.
Latest Patents
Bruce Innis holds a patent for a vaccine that pertains to methods for treating infections caused by human papillomaviruses. This invention has been recognized for its potential to provide cross-protection against various HPV types through immunization with HPV16 and HPV18 virus-like particles. He has 1 patent to his name, reflecting his innovative contributions to medical science.
Career Highlights
Innis is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His role there has allowed him to work on groundbreaking research and development projects that aim to improve vaccine efficacy and safety. His dedication to his work has positioned him as a key figure in the field of immunology.
Collaborations
Throughout his career, Bruce Innis has collaborated with esteemed colleagues such as Gary Dubin and Moncef Mohammed Slaoui. These partnerships have fostered an environment of innovation and have contributed to the advancement of vaccine research.
Conclusion
In summary, Bruce Innis is a prominent inventor whose work in vaccine development has the potential to impact public health significantly. His contributions, particularly in the realm of HPV, highlight the importance of innovation in combating infectious diseases.